Accure Therapeutics
PrivateLast Round
Grant
Apr 7, 2025
Total Funding Raised
$9.7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Accure Therapeutics is a biotechnology company that develops a portfolio of new drug candidates to treat Central Nervous System (CNS) diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Accure Therapeutics Comparables
Compare Accure Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nura Bio | 80% | |
| Addex Therapeutics | 79% | |
| Find Therapeutics | 79% | |
Accure Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 7, 2025 | ||||
| Series A | May 26, 2020 |
Accure Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Asabys Partners | Series A |
| Alta Life Sciences | Series A |
| Luxembourg National Research Fund | Grant |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| University of Barcelona | Grant, Series A |
| Center for Technological Development and Innovation | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Monthly visitors grew 44% MoM.
- Apr 7, 2025
$1.6M grant received
Accure Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Accure Therapeutics's valuation, stock price, and market status.